MIDOL BLOAT RELIEF DIN 02527324
Health Canada record
| Active ingredient(s) | PAMABROM 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | C03BD XANTHINE DERIVATIVES |
| Original market date | |
| Current status date | 13-May-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bayer Inc — licence 101029, currently licensed, last inspection rating C (2023-02-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PAMABROM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02242893 | DIUREX WATER CAPLETS | ALVA-AMCO PHARMACAL COMPANIES, LLC | Tablet | PAMABROM 50 MG | Cancelled Post Market |
| 02279207 | DIUREX WATER CAPSULES | ALVA-AMCO PHARMACAL COMPANIES, LLC | Capsule | PAMABROM 50 MG | Cancelled Pre Market |
International API supply for PAMABROM
0 active FDA Drug Master Files.
Request a quote for MIDOL BLOAT RELIEF